Literature DB >> 10421594

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

S S Franklin1, S A Khan, N D Wong, M G Larson, D Levy.   

Abstract

BACKGROUND: Current definitions of hypertension are based on levels of systolic blood pressure (SBP) and diastolic blood pressure (DBP), but not on pulse pressure (PP). We examined whether PP adds useful information for predicting coronary heart disease (CHD) in the population-based Framingham Heart Study. METHODS AND
RESULTS: We studied 1924 men and women between 50 and 79 years of age at baseline with no clinical evidence of CHD and not taking antihypertensive drug therapy. Cox regression, adjusted for age, sex, and other risk factors, was used to assess the relations between blood pressure components and CHD risk over a 20-year follow-up. The association with CHD risk was positive for SBP, DBP, and PP, considering each pressure individually; of the 3, PP yielded the largest chi(2) statistic. When SBP and DBP were jointly entered into the multivariable model, the association with CHD risk was positive for SBP (HR, 1.22; 95% CI, 1.15 to 1.30) and negative for DBP (HR, 0. 86; 95% CI, 0.75 to 0.98). Four subgroups were defined according to SBP levels (<120, 120 to 139, 140 to 159, and >/=160 mm Hg). Within each subgroup, the association with CHD risk was negative for DBP and positive for PP. A cross-classification of SBP-DBP levels confirmed these results.
CONCLUSIONS: In the middle-aged and elderly, CHD risk increased with lower DBP at any level of SBP>/=120 mm Hg, suggesting that higher PP was an important component of risk. Neither SBP nor DBP was superior to PP in predicting CHD risk.

Entities:  

Mesh:

Year:  1999        PMID: 10421594     DOI: 10.1161/01.cir.100.4.354

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  317 in total

1.  Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man.

Authors:  I B Wilkinson; H MacCallum; P C Hupperetz; C J van Thoor ; J R Cockcroft; D J Webb
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

2.  Isolated systolic hypertension: a radical rethink. It's a risk factor that needs treatment, especially in the over 50s.

Authors:  I B Wilkinson; D J Webb Christison; J R Cockcroft
Journal:  BMJ       Date:  2000-06-24

3.  The influence of heart rate on augmentation index and central arterial pressure in humans.

Authors:  I B Wilkinson; H MacCallum; L Flint; J R Cockcroft; D E Newby; D J Webb
Journal:  J Physiol       Date:  2000-05-15       Impact factor: 5.182

Review 4.  Using out of office blood pressure monitoring in the management of hypertension.

Authors:  P Verdecchia
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 5.  Matching the right drug to the right patient in essential hypertension.

Authors:  M J Brown
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

Review 6.  Systolic hypertension and cardiovascular risk reduction: a clinical review.

Authors:  W C Cushman
Journal:  Curr Hypertens Rep       Date:  2001-09       Impact factor: 5.369

Review 7.  The need to lower systolic blood pressure.

Authors:  S Shrivastava; M S Kochar
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 8.  Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?

Authors:  S S Franklin
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 9.  Hypertension: goal systolic and diastolic blood pressure.

Authors:  M R Weir
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

10.  Unmet needs in hypertension: challenges and opportunities.

Authors:  J D Jackson; P Merat
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.